SCHEMBL20628786

SCHEMBL20628786

CCCC(=O)CCC[C@H](N)c1nnco1

nearest known ligand 0.38

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CTSK P43235 2/20 0.38
GPR88 Q9GZN0 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11204502 0.65
SCHEMBL9823941 0.65 ALDH1A1 (0.44)
SCHEMBL652458 0.63 PAOX (0.52)
SCHEMBL23488070 0.63 CTSK (0.38) CTSKGPR88
SCHEMBL21030281 0.63 CTSK (0.38) CTSKGPR88
SCHEMBL105813 0.62 MAPT (0.41)
SCHEMBL16663701 0.60 MAPT (0.52)
SCHEMBL5194043 0.60 KMT2A (0.59)
SCHEMBL4890725 0.59 KMT2A (0.39)
SCHEMBL15011391 0.59 KMT2A (0.54)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3221313-B1 COMBINATION THERAPY FOR TREATMENT OF RESISTANT BACTERIAL INFECTIONS ENTASIS THERAPEUTICS LTD (GB) 2019-01-09 EP disclosed